Citation 8582

STEVENS,JF: MIRANDA,CL: WOLTHERS,KR: SCHIMERLIK,M: DEINZER,ML: BUHLER,DR:. (2002). IDENTIFICATION AND IN VITRO BIOLOGICAL ACTIVITIES OF HOP PROANTHOCYANIDINS: INHIBITION OF NNOS ACTIVITY AND SCAVENGING OF REACTIVE NITROGEN SPECIES.. 50(12)

Citation Details

Title	IDENTIFICATION AND IN VITRO BIOLOGICAL ACTIVITIES OF HOP PROANTHOCYANIDINS: INHIBITION OF NNOS ACTIVITY AND SCAVENGING OF REACTIVE NITROGEN SPECIES.
Authors	STEVENS,JF: MIRANDA,CL: WOLTHERS,KR: SCHIMERLIK,M: DEINZER,ML: BUHLER,DR:
Year	2002
Volume	50
Issue	12

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (1)

Humulus lupulus (CANNABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	NITRIC OXIDE SYNTHASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	NITRIC OXIDE SYNTHASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	LDL OXIDATION INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTED	PROCYANIDIN B-1	None
5	NITRIC OXIDE SYNTHASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROCYANIDIN B-1	WEAK ACTIVITY
6	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROCYANIDIN B-1	ACTIVE
7	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTED	PROCYANIDIN B-2	None
8	NITRIC OXIDE SYNTHASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROCYANIDIN B-2	ACTIVE
9	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROCYANIDIN B-2	ACTIVE
10	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTED	PROCYANIDIN B-3	None
11	NITRIC OXIDE SYNTHASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROCYANIDIN B-3	INACTIVE
12	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROCYANIDIN B-3	ACTIVE
13	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTED	PROCYANIDIN B-4	None
14	NITRIC OXIDE SYNTHASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROCYANIDIN B-4	ACTIVE
15	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROCYANIDIN B-4	ACTIVE
16	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTED	CATECHIN(4-BETA-8)-CATECHIN(4-ALPHA-8)-CATECHIN,EPI: (-):	None
17	NITRIC OXIDE SYNTHASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN(4-BETA-8)-CATECHIN(4-ALPHA-8)-CATECHIN,EPI: (-):	WEAK ACTIVITY
18	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN(4-BETA-8)-CATECHIN(4-ALPHA-8)-CATECHIN,EPI: (-):	ACTIVE
19	Not specified	IDENTIFICATION IN BY GC/MS	CATECHIN,(+):	None
20	NITRIC OXIDE SYNTHASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE
21	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
22	Not specified	IDENTIFICATION IN BY GC/MS	CATECHIN,EPI: (-):	None
23	NITRIC OXIDE SYNTHASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	INACTIVE
24	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	ACTIVE

Citation 8582

Citation Details

Summary

Organisms and Their Experiments (1)

Humulus lupulus (CANNABACEAE)

Show SPARQL Queries (1)

Query 1